MIDATECH PHARMA SP.ADR/25(5MP) News

Date	Title
Oct 4	Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma
Sep 26	Interim results for the six months ended June 30, 2024
Jul 11	Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data